Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Marj P. Zimmerman, BSPharm, MS
President
RxDirections
Bucyrus, KS
Authored Items
Is a Biologic Produced 15 Years Ago a Biosimilar of Itself Today?
Stanton R. Mehr
,
Marj P. Zimmerman, BSPharm, MS
December 2016 Vol 9, No 9
in
Biosimilars
Reviewing the Unmet Needs of Patients with Multiple Sclerosis
Stanton R. Mehr
,
Marj P. Zimmerman, BSPharm, MS
November 2015 Vol 8, No 8
in
Clinical
How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?
Marj P. Zimmerman, BSPharm, MS
November 2015 Vol 8, No 8
in
Clinical
Last modified: December 19, 2016
